$4.760
-0.069 (-1.45%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de CSBR por análisis de gráficos similares
Alphio's CSBR stock price prediction model matches the current Champions Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.66 (-2.16%). The 1-week path is $4.79 (+0.68%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Champions Oncology Inc?
Champions Oncology Inc (CSBR) is currently priced at $4.81, which is near the 52-week low of $4.59. The stock has a forward P/E ratio of 22.88, indicating potential for growth, but it has experienced a significant year-to-date decline of 27.78%. The RSI is at 47.60, suggesting the stock is neither overbought nor oversold. The main risk is its negative net income trend, with a net loss of $667,000 in the last quarter, which raises concerns about profitability moving forward.
CSBR cerró en $4.76 el Thursday, tras bajar -1.45%
Champions Oncology Inc (CSBR) last closed at $4.7600002, losing -1.45%. These facts feed the 1-day and 1-week CSBR price prediction above.
Consenso de analistas
Champions Oncology Inc (CSBR): 1 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Champions Oncology Inc (CSBR) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de CSBR, ordenadas por similitud.
Análisis de estacionalidad de CSBR
Historically the probability of a positive November return for CSBR is 0.00%. January offers the highest probability of a positive month at 93.44%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de CSBR
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $8.15 | $8.46 | $9.50 | +77.70% |
| Dec 2026 | $6.97 | $7.86 | $7.89 | +65.11% |
En 2026, se proyecta que Champions Oncology Inc (CSBR) oscile entre $6.97 y $9.50.
Previsión mensual de Champions Oncology Inc para 2026
En Nov de 2026, se proyecta que Champions Oncology Inc promedie $8.46, con un mínimo de $8.15 y un máximo de $9.50.
En Dec de 2026, se proyecta que Champions Oncology Inc promedie $7.86, con un mínimo de $6.97 y un máximo de $7.89.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.